Acumen Pharmaceuticals Inc (ABOS)
3.655
-0.08
(-2.01%)
USD |
NASDAQ |
May 17, 16:00
3.655
0.00 (0.00%)
After-Hours: 20:00
Acumen Pharmaceuticals Total Liabilities (Quarterly): 38.93M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 38.93M |
December 31, 2023 | 43.15M |
September 30, 2023 | 6.098M |
June 30, 2023 | 8.531M |
March 31, 2023 | 8.779M |
December 31, 2022 | 7.812M |
September 30, 2022 | 6.613M |
Date | Value |
---|---|
June 30, 2022 | 5.159M |
March 31, 2022 | 3.998M |
December 31, 2021 | 5.147M |
September 30, 2021 | 1.489M |
June 30, 2021 | 179.02M |
March 31, 2021 | 87.84M |
December 31, 2020 | 63.02M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.489M
Minimum
Sep 2021
179.02M
Maximum
Jun 2021
33.26M
Average
8.172M
Median
Total Liabilities (Quarterly) Benchmarks
Accuray Inc | 421.45M |
Kezar Life Sciences Inc | 30.01M |
Akoya Biosciences Inc | 122.03M |
NovaBay Pharmaceuticals Inc | 5.197M |
Palatin Technologies Inc | 9.827M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 300.97M |
Shareholders Equity (Quarterly) | 262.03M |